Insiders TherapeuticsMD, Inc.

Equities

TXMD

US88338N2062

Market Closed - Nasdaq Other stock markets 16:00:00 2024-06-25 EDT			5-day change	1st Jan Change
1.81 ^USD	0.00%		-2.69%	-19.56%

05-10	TherapeuticsMD, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
05-10	TherapeuticsMD, Inc. Continues Evaluation of Strategic Alternatives	CI

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

TherapeuticsMD, Inc. Announces Executive Changes	23-08-18	CI
TherapeuticsMd, Inc. Announces Chief Executive Officer Changes	23-01-06	CI
TherapeuticsMd, Inc. Announces Executive Changes	23-01-06	CI
Services Data and Factory Orders Anticipation Drag Exchange-Traded Funds, Stock Futures Lower	22-12-05	MT
TherapeuticsMD Appoints Brian Bernick, Mark Glickman as Interim Co-CEOs	22-09-12	MT
Therapeuticsmd, Inc. Announces Chief Executive Officer Changes	22-09-12	CI
Therapeuticsmd, Inc. Appoints Tommy Thompson as Executive Chairman of the Board	22-09-12	CI
TherapeuticsMD, Inc. Appoints Justin Roberts as A Director	22-08-29	CI
Haemonetics Appoints James D'Arecca as Chief Financial Officer	22-03-21	MT
Haemonetics Names New Chief Financial Officer; Incumbent Retiring	22-03-21	MT
TherapeuticsMD, Inc. Announces Executive Changes, Effective April 1, 2022	22-03-18	CI
Robert G. Finizio Notifies TherapeuticsMD, Inc. of His Decision to Resign from the Board of Directors of the Company and as Vice Chair	22-02-18	CI
TherapeuticsMD, Inc. Announces Chief Executive Officer Changes	21-12-20	CI
TherapeuticsMD, Inc. Appoints Hugh O’Dowd as a Director	21-12-20	CI
TherapeuticsMD, Inc. Announces Resignation of J. Martin Carroll from Board of Directors, Effective December 31, 2021	21-12-17	CI
Insider Buy: Therapeuticsmd	21-11-22	MT
TherapeuticsMD Appoints Hugh O'Dowd Chief Executive	21-11-11	MT
Therapeuticsmd, Inc. Announces CEO Changes	21-11-11	CI
TherapeuticsMD, Inc. Announces Executive Changes	21-11-11	CI
TherapeuticsMD, Inc. Announces Appointment of Mark Glickman as Chief Business Officer	21-10-15	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders TherapeuticsMD, Inc.

Equities

TXMD

US88338N2062

Insiders

Filters